Pemigatinib 13.5mg tablets
- SNOMED code
39934311000001103- Active compound
- Pemigatinib
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 tablet, tablet
- Ingredients
- Pemigatinib
— 13.5 mg
based on ingredient substance
- Form & Route
- tablet.oral
Oral tablet, Oral - Controlled drug
- No Controlled Drug Status
Products
Pemazyre 13.5mg tablets (Incyte Biosciences UK Ltd)
Pemazyre 13.5mg tablets
- SNOMED code
39929311000001104- Supplier
- Incyte Biosciences UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Oral
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Pemazyre 13.5mg tablets (Incyte Biosciences UK Ltd) 14 tablet39929411000001106 ref. pack | 💯 Available Legal category: POM | 07640159430766End: 7640159430766End: 07640159430766 | NHS Indicative Price £7,159 previously: £7,159 | • Hospital |
| — |
Reference packs
Pemigatinib 13.5mg tablets 14 tablet
- SNOMED code
39929211000001107- Quantity and unit
- 14 tablet
- Packs